MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers

por Plantamura, Ilaria, Cosentino, Giulia, Cataldo, Alessandra
Publicado 2018

MicroRNA and Oxidative Stress Interplay in the Context of Breast Cancer Pathogenesis

por Cosentino, Giulia, Plantamura, Ilaria, Cataldo, Alessandra, Iorio, Marilena V.
Publicado 2019

miR-205 in Breast Cancer: State of the Art

por Plantamura, Ilaria, Cataldo, Alessandra, Cosentino, Giulia, Iorio, Marilena V.
Publicado 2020

Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay

por Cosentino, Giulia, Plantamura, Ilaria, Tagliabue, Elda, Iorio, Marilena V., Cataldo, Alessandra
Publicado 2021

miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts

por Cosentino, Giulia, Romero-Cordoba, Sandra, Plantamura, Ilaria, Cataldo, Alessandra, Iorio, Marilena V.
Publicado 2020

High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors

por Sommariva, Michele, de Cesare, Michelandrea, Meini, Alessandra, Cataldo, Alessandra, Zaffaroni, Nadia, Tagliabue, Elda, Balsari, Andrea
Publicado 2013

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer

por Cataldo, Alessandra, Romero-Cordoba, Sandra, Plantamura, Ilaria, Cosentino, Giulia, Hidalgo-Miranda, Alfredo, Tagliabue, Elda, Iorio, Marilena V.
Publicado 2020

The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective

por Fogazzi, Valentina, Kapahnke, Marcel, Cataldo, Alessandra, Plantamura, Ilaria, Tagliabue, Elda, Di Cosimo, Serena, Cosentino, Giulia, Iorio, Marilena V.
Publicado 2022

miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response

por Cataldo, Alessandra, Cheung, Douglas G., Balsari, Andrea, Tagliabue, Elda, Coppola, Vincenzo, Iorio, Marilena V., Palmieri, Dario, Croce, Carlo M.
Publicado 2015

Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation

por De Cecco, Loris, Berardi, Martina, Sommariva, Michele, Cataldo, Alessandra, Canevari, Silvana, Mezzanzanica, Delia, Iorio, Marilena V., Tagliabue, Elda, Balsari, Andrea
Publicado 2013

MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab

por Cataldo, Alessandra, Piovan, Claudia, Plantamura, Ilaria, D’Ippolito, Elvira, Camelliti, Simone, Casalini, Patrizia, Giussani, Marta, Déas, Olivier, Cairo, Stefano, Judde, Jean-Gabriel, Tagliabue, Elda, Iorio, Marilena V.
Publicado 2018

Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain

por Camelliti, Simone, Le Noci, Valentino, Bianchi, Francesca, Storti, Chiara, Arnaboldi, Francesca, Cataldo, Alessandra, Indino, Serena, Jachetti, Elena, Figini, Mariangela, Colombo, Mario Paolo, Balsari, Andrea, Gagliano, Nicoletta, Tagliabue, Elda, Sfondrini, Lucia, Sommariva, Michele
Publicado 2021

What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study

por Pizzamiglio, Sara, Cosentino, Giulia, Ciniselli, Chiara M., De Cecco, Loris, Cataldo, Alessandra, Plantamura, Ilaria, Triulzi, Tiziana, El‐abed, Sarra, Wang, Yingbo, Bajji, Mohammed, Nuciforo, Paolo, Huober, Jens, Ellard, Susan L., Rimm, David L., Gombos, Andrea, Daidone, Maria Grazia, Verderio, Paolo, Tagliabue, Elda, Di Cosimo, Serena, Iorio, Marilena V.
Publicado 2021